On 12/6/23, TG Therapeutics Inc (NASDAQ: TGTX) stock enjoyed a major increase of 14.9%, closing at $16.45. Moreover, this advance was accompanied by above average trading volume at 145% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 30.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, TGTX is expected to continue to be a modest Value Eraser.
TG Therapeutics has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. TG Therapeutics has a poor Power Rating of 21 and a very low Appreciation Score of 1, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment